YDES
YDES
NASDAQ · Biotechnology

Yd Bio Ltd

$2.42
-0.10 (-3.97%)
Financial Highlights (FY 2026)
Revenue
466.5K
Net Income
-6,531,474
Gross Margin
28.0%
Profit Margin
-1,392.6%
Rev Growth
D/E Ratio
0.01
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 28.0% 43.0% 43.0% 43.0%
Operating Margin -883.3% 23.0% 23.0% 20.8%
Profit Margin -1,392.6% 23.8% 21.7% 19.2%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 466.5K 122.20M 119.09M 134.19M
Gross Profit 130.9K 52.52M 51.18M 57.67M
Operating Income -4,120,885 28.12M 27.40M 27.90M
Net Income -6,531,474 29.08M 25.78M 25.78M
Gross Margin 28.0% 43.0% 43.0% 43.0%
Operating Margin -883.3% 23.0% 23.0% 20.8%
Profit Margin -1,392.6% 23.8% 21.7% 19.2%
Rev Growth +2.9% +5.6% -10.0%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 485.8K 239.43M 188.25M 198.79M
Total Equity 85.22M 534.41M 574.88M 548.17M
D/E Ratio 0.01 0.45 0.33 0.36
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -4,130,659 41.35M 38.15M 43.54M
Free Cash Flow 33.20M 25.74M 34.14M